Regulations and Regulatory Advocacy
A new memorandum from the Centers for Medicare & Medicaid Services is reinforcing the agency’s role in enforcing regulatory expectations that patients and hospital staff have an environment that prioritizes their safety to ensure effective delivery of health care.
The AHA letter to the Centers for Medicare & Medicaid Services, cautioning against softening standards designed to maintain the safety and quality of laboratory testing in the U.S., including those regulating the professionals who staff the nation’s Clinical Laboratory Improvement Amendments-…
The Centers for Disease Control and Prevention yesterday updated its guidance to help clinicians evaluate and test patients with relevant history, signs and symptoms for monkeypox
AHA Friday urged lawmakers to consider certain changes to the Verifying Accurate Leading-Edge IVCT Development (VALID) Act.
AHA provides feedback on the Food and Drug Administration
Safety and Landmark Advancements (FDASLA) Act (S.4348).
HHS today withdrew the Trump Administration rule, as advocated by the AHA.
AHA policy staff urged the agency not to finalize the regulation, saying it's unnecessary and would cause confusion.
The association said the OSHA standard is unnecessary and would cause confusion.
The agency said the state has failed to adopt its emergency temporary standard for occupational exposure to COVID-19 and has a history of failing to meet its obligations under the plan.
AHA has urged the agencies to update their merger guidelines.